Position in INCY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$29,367,416
+$15,900,818 QoQ
Shares Held
312,021
+128.9% QoQ
Ownership
0.156%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Derivatives in INCY
reported options exposure · as of Mar 31, 2026CallValue
$1,176,500
CallShares
12,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPITAL FUND MANAGEMENT S.A. holds $292,594,996 across 34 Biotechnology names. INCY ranks #3 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
122,934 | $54,894,948 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
140,109 | $46,357,864 | |
| 3 | INCY |
Incyte Corp
This page
|
312,021 | $29,367,416 | |
| 4 | MRNA |
Moderna, Inc.
|
569,930 | $28,952,444 | |
| 5 | EXEL |
Exelixis, Inc.
|
479,693 | $20,574,032 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
174,378 | $11,270,050 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
142,201 | $10,677,873 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
181,065 | $10,228,361 |
All Filings in INCY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,367,416 | 312,021 | Shares | Sole | 2026-05-14 | |
| 2026-03-31 | $1,176,500 | 12,500 | Call | Sole | 2026-05-14 | |
| 2025-12-31 | $13,466,598 | 136,343 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,515,708 | 241,902 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $22,249,223 | 326,714 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,982,801 | 181,384 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $21,294,419 | 308,302 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $786,590 | 11,900 | Put | Sole | 2024-11-13 | |
| 2024-09-30 | $25,270,228 | 382,303 | Shares | Sole | 2024-11-13 | |
| 2024-09-30 | $694,050 | 10,500 | Call | Sole | 2024-11-13 | |
| 2024-06-30 | $14,234,000 | 234,807 | Shares | Sole | 2024-08-13 | |
| 2024-06-30 | $1,236,648 | 20,400 | Put | Sole | 2024-08-13 | |
| 2024-06-30 | $1,024,478 | 16,900 | Call | Sole | 2024-08-13 | |
| 2024-03-31 | $8,754,408 | 153,667 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $1,202,067 | 21,100 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $1,783,161 | 31,300 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $6,385,743 | 101,700 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $10,357,022 | 164,947 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $7,785,960 | 124,000 | Put | Sole | 2024-02-14 | |
| 2023-09-30 | $2,120,159 | 36,700 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $1,502,020 | 26,000 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $8,048,285 | 139,316 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,931,288 | 111,346 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,617,041 | 36,212 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $1,124,350 | 16,872 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $1,270,921 | 17,315 | Shares | Sole | 2022-02-10 | |
| 2020-03-31 | $10,377,350 | 141,709 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||